Could milk-derived nanoparticles change bile duct cancer care? July 16, 2026 Overview Mostrar la transcripción Overview A "Tomorrow's Cure" podcast episode from Mayo Clinic explores cholangiocarcinoma, a rare and difficult-to-treat bile duct cancer. Host Lindsey Seavert speaks with Rory L. Smoot, M.D., a Mayo Clinic surgical oncologist, and Melinda Bachini, a long-term survivor and patient advocate. They discuss symptoms, diagnosis, treatment challenges, clinical trials and the value of second opinions. The episode highlights promising research and the growing momentum toward personalized treatments. VID-20608626 Profesionales médicos Could milk-derived nanoparticles change bile duct cancer care?